SCHEMBL3606928

SCHEMBL3606928

O=C(O)NCc1cc(-c2cccnc2)no1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.62
CYP2C19 P33261 3/20 0.62
CYP2E1 P05181 1/20 0.62
CYP2A6 P11509 1/20 0.62
CYP2B6 P20813 1/20 0.62
NAMPT P43490 1/20 0.52
POLB P06746 2/20 0.49
SMN1; SMN2 Q16637 4/20 0.48
ALDH1A1 P00352 3/20 0.48
HTT P42858 2/20 0.48
JAK2 O60674 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
RAB9A P51151 1/20 0.47
KMT2A Q03164 1/20 0.47
CYP1A2 P05177 3/20 0.47
NOTUM Q6P988 1/20 0.47
LMNA P02545 2/20 0.46
MAPK1 P28482 1/20 0.46
CA12 O43570 1/20 0.46
CA9 Q16790 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6401623 0.87 NOTUM (0.61) CYP2C19POLBSMN1; SMN2ALDH1A1HTT
SCHEMBL6408022 0.84 CYP2E1 (0.53) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL20791734 0.84 ROCK2 (0.59) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL3861145 0.82 CYP2E1 (0.53) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL6403360 0.82 SIRT2 (0.55) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL22195036 0.82 CYP2C9 (0.67) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL19080614 0.82 CYP2C9 (0.67) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL22191578 0.81 CYP2C9 (0.65) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL27163520 0.80 CYP2A6 (0.72) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL20810144 0.78 NPC1 (0.53) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609708-B2 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2013-12-17 US disclosed
US-20100298345-A1 SYNTHETIC COMPOUNDS AND DERIVATIVES AS MODULATORS OF SMOKING OR NICOTINE INGESTION AND LUNG CANCER HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2010-11-25 US disclosed
US-20080188527-A1 Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer HUMAN BIOMOLECULAR RESEARCH INSTITUTE 2008-08-07 US disclosed
WO-2005066162-A1 SYNTHETIC COMPOUNDS AND DERIVATIVES AS MODULATORS OF SMOKING OR NICOTINE INGESTION AND LUNG CANCER HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2005-07-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188527-A1 Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer CYP2A13, CYP2A6, CYP2B6 CYP2C9 44/4885CYP2C19 41/4885CYP2E1 46/4885
US-20100298345-A1 SYNTHETIC COMPOUNDS AND DERIVATIVES AS MODULATORS OF SMOKING OR NICOTINE INGESTION AND LUNG CANCER CYP2A13, CYP2A6, CYP2B6 CYP2C9 44/4885CYP2C19 41/4885CYP2E1 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.